Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

PD‐L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment

Open access

Abstract

The coinhibitory receptor, PD-1, is of major importance for the suppression of T cell activation in various types of immune responses. A high-resolution imaging study showed that PD-1 forms a coinhibitory signalosome, "PD-1 microcluster", with the phosphatase, SHP2, to dephosphorylate the TCR/CD3 complex and its downstream signaling molecules. Such a consecutive reaction entirely depended on PD-1-PD-L1/2 binding. PD-L2 is expressed on professional antigen-presenting cells and also on some tumor cells, which possibly explains the discrepant efficacy of immune checkpoint therapy for PD-L1-negative tumors. Here, we performed precise imaging analysis of PD-L2 forming PD-1-PD-L2 clusters associating with SHP2. PD-L2 could compete with PD-L1 for binding to PD-1, occupying the same space at TCR microclusters. The PD-1 microcluster formation was inhibited by certain mAbs with functional consequences. Thus, PD-1 microcluster formation provides a visible index for the effectiveness of anti-PD-1- or anti-PD-L1/2-mediated T cell suppression. PD-L2 may exert immune suppressive responses cooperatively with PD-L1 on the microcluster scale.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-021-02111-3

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Translocation of PD-1 at TCR microclusters introduced by PD-1–PD-L1 or PD-1–PD-L2 binding. a CD4+ T cells were purified from AND-Tg Pdcd1−/− Rag2−/− mice, stimulated with irradiated B10.BR whole splenocytes with 5 μM MCC88–103 peptides, and retrovirally transduced with mouse (m) PD-1–EGFP. The cells were plated onto an MCC88–103-prepulsed SLB containing I-Ek–GPI (200/μm2) and mICAM-1–GPI (100/μm2) without (top) or with mouse mPD-L1–GPI (middle, 150/μm2) or mPD-L2–GPI (bottom, 150/μm2) and real-time imaged by total internal reflection fluorescence microscopy (times are above images; Supplementary Movie 1). b Clustering and centripetal movement of PD-1 on the diagonal yellow line in a is presented as horizontal elements in kymographs. c Primary CD4+ T cells expressing mPD-1–EGFP (green) in a were prestained with DyLight 650-labeled anti-TCRβ (H57) Fab (red), plated onto an SLB as in a and real-time imaged by confocal microscopy at 2 (left) or 10 (right) min after contact. Histograms show fold fluorescent intensities of TCRβ (red) and mPD-1 (green) on the diagonal yellow lines in the DIC images. d CD8+ T cells were purified from OT-I-Tg Rag2−/− mice, stimulated with irradiated C57BL/6 whole splenocytes with 100 nM OVA257–264 peptide and retrovirally transduced with PD-1–EGFP. The cells were imaged as in a on an SLB containing OVA257–264-prepulsed H2-Kb–GPI (200/μm2). Histograms are depicted as in c. e The graph shows the percentage of TCR microclusters colocalized with mPD-1 at 2 min after contact in CD4+ T cells in c (left) and CD8+ T cells in d (right) (n = 5). f AND-TCR T cell hybridomas (2D12) expressing mPD-1–EGFP were prestained with DyLight 650-labeled H57 Fab (red), conjugated with an MCC88–103 prepulsed (5 μM) I-Ek-expressing APC line, DC-1 cell, not expressing (top) or expressing mPD-L1 (middle) or mPD-L2 (bottom) and real-time imaged by confocal microscopy at 2 min after contact. Histograms show fold fluorescent intensities of TCRβ (red) and mPD-1 (green) on the diagonal yellow lines in the DIC images. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). ****p < 0.0001.
Fig. 1 Translocation of PD-1 at TCR microclusters introduced by PD-1–PD-L1 or PD-1–PD-L2 binding. a CD4+ T cells were purified from AND-Tg Pdcd1−/− Rag2−/− mice, stimulated with irradiated B10.BR whole splenocytes with 5 μM MCC88–103 peptides, and retrovirally transduced with mouse (m) PD-1–EGFP. The cells were plated onto an MCC88–103-prepulsed SLB containing I-Ek–GPI (200/μm2) and mICAM-1–GPI (100/μm2) without (top) or with mouse mPD-L1–GPI (middle, 150/μm2) or mPD-L2–GPI (bottom, 150/μm2) and real-time imaged by total internal reflection fluorescence microscopy (times are above images; Supplementary Movie 1). b Clustering and centripetal movement of PD-1 on the diagonal yellow line in a is presented as horizontal elements in kymographs. c Primary CD4+ T cells expressing mPD-1–EGFP (green) in a were prestained with DyLight 650-labeled anti-TCRβ (H57) Fab (red), plated onto an SLB as in a and real-time imaged by confocal microscopy at 2 (left) or 10 (right) min after contact. Histograms show fold fluorescent intensities of TCRβ (red) and mPD-1 (green) on the diagonal yellow lines in the DIC images. d CD8+ T cells were purified from OT-I-Tg Rag2−/− mice, stimulated with irradiated C57BL/6 whole splenocytes with 100 nM OVA257–264 peptide and retrovirally transduced with PD-1–EGFP. The cells were imaged as in a on an SLB containing OVA257–264-prepulsed H2-Kb–GPI (200/μm2). Histograms are depicted as in c. e The graph shows the percentage of TCR microclusters colocalized with mPD-1 at 2 min after contact in CD4+ T cells in c (left) and CD8+ T cells in d (right) (n = 5). f AND-TCR T cell hybridomas (2D12) expressing mPD-1–EGFP were prestained with DyLight 650-labeled H57 Fab (red), conjugated with an MCC88–103 prepulsed (5 μM) I-Ek-expressing APC line, DC-1 cell, not expressing (top) or expressing mPD-L1 (middle) or mPD-L2 (bottom) and real-time imaged by confocal microscopy at 2 min after contact. Histograms show fold fluorescent intensities of TCRβ (red) and mPD-1 (green) on the diagonal yellow lines in the DIC images. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). ****p < 0.0001.CC BY · PubMed Central
Fig. 2 Each blocking antibody for PD-1, PD-L1, or PD-L2 requires its own concentration to block PD-1 microcluster formation. a 2D12 expressing mPD-1–EGFP (green) cells were prestained with DyLight 650–labeled H57 Fab (red) and plated on an SLB with mPD-L1–GPI (left two columns) or mPD-L2–GPI (right two columns) as in Fig. 1a. The cells were real-time imaged by confocal microscopy at 2 min after contact in the absence (top) or presence of anti-PD-1 (29F.1A12, row 2), anti-PD-L1 (MIH5, row 3), anti-PD-L2 (MIH37, row 4) or both anti-PD-L1 and anti-PD-L2 (bottom). b The graph shows the percentage of T cells forming PD-1 microclusters in a (n = 30). c 2D12 expressing mPD-1–EGFP were imaged as in a in the absence (top) or presence of three different anti-PD-1 mAbs, J43 (row 2 and 3), RMP1-14 (row 4 and 5) or 29 F.1A12 (bottom) at a concentration of 10 or 50 μg/ml. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). ****p < 0.0001.
Fig. 2 Each blocking antibody for PD-1, PD-L1, or PD-L2 requires its own concentration to block PD-1 microcluster formation. a 2D12 expressing mPD-1–EGFP (green) cells were prestained with DyLight 650–labeled H57 Fab (red) and plated on an SLB with mPD-L1–GPI (left two columns) or mPD-L2–GPI (right two columns) as in Fig. 1a. The cells were real-time imaged by confocal microscopy at 2 min after contact in the absence (top) or presence of anti-PD-1 (29F.1A12, row 2), anti-PD-L1 (MIH5, row 3), anti-PD-L2 (MIH37, row 4) or both anti-PD-L1 and anti-PD-L2 (bottom). b The graph shows the percentage of T cells forming PD-1 microclusters in a (n = 30). c 2D12 expressing mPD-1–EGFP were imaged as in a in the absence (top) or presence of three different anti-PD-1 mAbs, J43 (row 2 and 3), RMP1-14 (row 4 and 5) or 29 F.1A12 (bottom) at a concentration of 10 or 50 μg/ml. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). ****p < 0.0001.CC BY · PubMed Central
Fig. 3 SHP2, but not SHP1, is rapidly and transiently recruited to PD-1 microclusters. a 2D12 transduced with both mPD-1–HaloTag and EGFP–SHP1 (left) or EGFP–SHP2 (right) were preincubated with the HaloTag ligand–Stella650 (red), plated onto the SLB as in Fig. 1a without (top) or with mPD-L1–GPI (150/μm2, middle) or mPD-L2–GPI (150/μm2, bottom) and real-time imaged by confocal microscopy at 20 s after contact. Histograms show fold fluorescent intensities of mPD-1 (red) and SHP1 (green) or SHP2 (green) on the diagonal yellow lines in the DIC images. b The cells in a (SHP1, left panel; SHP2, right panel) were conjugated with DC-1 cells not expressing (top) or expressing mPD-L1 (middle) or mPD-L2 (bottom) and real-time imaged by confocal microscopy at 20 s after contact. Histograms show fold fluorescent intensities of PD-1(red) and SHP1 (green, left panel) or SHP2 (green, right panel) on the diagonal yellow lines in the DIC images. c 2D12 expressing mPD-1–EGFP were conjugated by MCC88–103-prepulsed (5 μM) DC-1 cells (left) or DC-1 expressing mPD-L1 (middle) or mPD-L2 (right) for the indicated times. The cells were lysed, immunoprecipitated for PD-1 by anti-GFP and blotted for SHP1, SHP2, or PD-1. The whole cell lysates (WCLs) were blotted for SHP1, SHP2, or PD-1. The number below each line represents the intensity of the band. All data are representatives of three independent experiments. Bars, 5 μm.
Fig. 3 SHP2, but not SHP1, is rapidly and transiently recruited to PD-1 microclusters. a 2D12 transduced with both mPD-1–HaloTag and EGFP–SHP1 (left) or EGFP–SHP2 (right) were preincubated with the HaloTag ligand–Stella650 (red), plated onto the SLB as in Fig. 1a without (top) or with mPD-L1–GPI (150/μm2, middle) or mPD-L2–GPI (150/μm2, bottom) and real-time imaged by confocal microscopy at 20 s after contact. Histograms show fold fluorescent intensities of mPD-1 (red) and SHP1 (green) or SHP2 (green) on the diagonal yellow lines in the DIC images. b The cells in a (SHP1, left panel; SHP2, right panel) were conjugated with DC-1 cells not expressing (top) or expressing mPD-L1 (middle) or mPD-L2 (bottom) and real-time imaged by confocal microscopy at 20 s after contact. Histograms show fold fluorescent intensities of PD-1(red) and SHP1 (green, left panel) or SHP2 (green, right panel) on the diagonal yellow lines in the DIC images. c 2D12 expressing mPD-1–EGFP were conjugated by MCC88–103-prepulsed (5 μM) DC-1 cells (left) or DC-1 expressing mPD-L1 (middle) or mPD-L2 (right) for the indicated times. The cells were lysed, immunoprecipitated for PD-1 by anti-GFP and blotted for SHP1, SHP2, or PD-1. The whole cell lysates (WCLs) were blotted for SHP1, SHP2, or PD-1. The number below each line represents the intensity of the band. All data are representatives of three independent experiments. Bars, 5 μm.CC BY · PubMed Central
Fig. 4 PD-1–PD-L1 or PD-1–PD-L2 binding attenuates the phosphorylation of both TCR/CD3 complex and its downstream signaling molecules. a 2D12 transduced with mPD-1–HaloTag were preincubated with the HaloTag ligand–TMR (cyan) and DyLight 488-labeled H57 Fab (green), plated onto the SLB as in Fig. 1a without (top) or with mPD-L1–GPI (150/μm2, middle) or mPD-L2–GPI (150/μm2, bottom), fixed at 2 min after contact, stained with Alexa Fluor 647-labeled anti-phospho (p) CD3ζ (red) and imaged by confocal microscopy. Histograms show fold fluorescent intensities of TCRβ (green), PD-1 (cyan) and pCD3ζ (red) on the diagonal yellow lines in the DIC images. b The graph shows pCD3ζ/TCRβ fluorescent intensity ratio at the T cell-bilayer interface in a in the absence (left) or presence of mPD-L1–GPI (middle) or mPD-L2–GPI (right) (n = 20). Horizontal bars, average. c Primary CD4+ T cells in Fig. 1c transduced with mPD-1–GFP (green) were prestained with the DyLight 549-labeled H57 Fab (cyan), plated onto the SLB, fixed, stained for pCD3ζ (red, left panel) or pSLP-76 (red, right panel) and imaged as in a. Histograms show fold fluorescent intensities of TCRβ (cyan), PD-1 (green) and pCD3ζ or pSLP-76 (red) on the diagonal yellow lines in the middle column. d The graphs show fluorescent intensity ratio of pCD3ζ/TCRβ (top) or pSLP-76/TCRβ (bottom) in c in the absence or presence of mPD-L1–GPI or mPD-L2–GPI (n = 20). Horizontal bars, average. e 2D12 expressing mPD-1 were stimulated with MCC88–103-prepulsed DC-1 cells not expressing (left) or expressing mPD-L1 (middle) or mPD-L2 (right) for the indicated times. The WCLs were blotted for pPLCγ1, PLCγ1, pErk1/2, or Erk1/2. The number below each line represents the intensity ratio, pPLCγ/PLCγ or pErk/Erk. f The cells in e were stimulated by 16h-aggregation culture with DC-1 cells (black) or those expressing mPD-L1 (red) or mPD-L2 (green) under the different concentrations of MCC88–103 and the concentration of IL-2 in each supernatant was measured by ELISA. g The cells in e were stimulated by 16 h-aggregation culture with MCC88–103 and DC-1 cells expressing mPD-L1 or mPD-L2 in the absence or presence of each antibody as in Fig. 2a and the concentration of IL-2 in each supernatant was measured by ELISA. h The target cell, EL-4 cell, is introduced by RLuc8 and further by mPD-L1 (red) or mPD-L2 (green). Effector primary CD8+ T cells expressing mPD-1 were cocultured with 1 nM OVA257–264-pulsed these target EL-4 cells at the indicated E:T ratios for 16 h with or without 10 μg/ml anti-PD-1 (29F.1A12). After treatment with RLuc8 substrate, the intensity of live cells was measured and the percent specific lysis was calculated. i The concentration of IFNγ in culture supernatants in h was measured by ELISA. j The cells in e were stimulated by 16 h-aggregation culture with 10 μM MCC88–103 and DC-1 cells expressing mPD-L1 and mPD-L2 in the absence or presence of anti-PD-1 (J43: brown, RMP1-14: blue, 29F.1A12: green) as in Fig. 2c at the indicated concentrations and the concentration of IL-2 in each supernatant was measured by ELISA. The right graph shows the recovery rate of IL-2 production by each anti-PD-1 at the different concentrations. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Fig. 4 PD-1–PD-L1 or PD-1–PD-L2 binding attenuates the phosphorylation of both TCR/CD3 complex and its downstream signaling molecules. a 2D12 transduced with mPD-1–HaloTag were preincubated with the HaloTag ligand–TMR (cyan) and DyLight 488-labeled H57 Fab (green), plated onto the SLB as in Fig. 1a without (top) or with mPD-L1–GPI (150/μm2, middle) or mPD-L2–GPI (150/μm2, bottom), fixed at 2 min after contact, stained with Alexa Fluor 647-labeled anti-phospho (p) CD3ζ (red) and imaged by confocal microscopy. Histograms show fold fluorescent intensities of TCRβ (green), PD-1 (cyan) and pCD3ζ (red) on the diagonal yellow lines in the DIC images. b The graph shows pCD3ζ/TCRβ fluorescent intensity ratio at the T cell-bilayer interface in a in the absence (left) or presence of mPD-L1–GPI (middle) or mPD-L2–GPI (right) (n = 20). Horizontal bars, average. c Primary CD4+ T cells in Fig. 1c transduced with mPD-1–GFP (green) were prestained with the DyLight 549-labeled H57 Fab (cyan), plated onto the SLB, fixed, stained for pCD3ζ (red, left panel) or pSLP-76 (red, right panel) and imaged as in a. Histograms show fold fluorescent intensities of TCRβ (cyan), PD-1 (green) and pCD3ζ or pSLP-76 (red) on the diagonal yellow lines in the middle column. d The graphs show fluorescent intensity ratio of pCD3ζ/TCRβ (top) or pSLP-76/TCRβ (bottom) in c in the absence or presence of mPD-L1–GPI or mPD-L2–GPI (n = 20). Horizontal bars, average. e 2D12 expressing mPD-1 were stimulated with MCC88–103-prepulsed DC-1 cells not expressing (left) or expressing mPD-L1 (middle) or mPD-L2 (right) for the indicated times. The WCLs were blotted for pPLCγ1, PLCγ1, pErk1/2, or Erk1/2. The number below each line represents the intensity ratio, pPLCγ/PLCγ or pErk/Erk. f The cells in e were stimulated by 16h-aggregation culture with DC-1 cells (black) or those expressing mPD-L1 (red) or mPD-L2 (green) under the different concentrations of MCC88–103 and the concentration of IL-2 in each supernatant was measured by ELISA. g The cells in e were stimulated by 16 h-aggregation culture with MCC88–103 and DC-1 cells expressing mPD-L1 or mPD-L2 in the absence or presence of each antibody as in Fig. 2a and the concentration of IL-2 in each supernatant was measured by ELISA. h The target cell, EL-4 cell, is introduced by RLuc8 and further by mPD-L1 (red) or mPD-L2 (green). Effector primary CD8+ T cells expressing mPD-1 were cocultured with 1 nM OVA257–264-pulsed these target EL-4 cells at the indicated E:T ratios for 16 h with or without 10 μg/ml anti-PD-1 (29F.1A12). After treatment with RLuc8 substrate, the intensity of live cells was measured and the percent specific lysis was calculated. i The concentration of IFNγ in culture supernatants in h was measured by ELISA. j The cells in e were stimulated by 16 h-aggregation culture with 10 μM MCC88–103 and DC-1 cells expressing mPD-L1 and mPD-L2 in the absence or presence of anti-PD-1 (J43: brown, RMP1-14: blue, 29F.1A12: green) as in Fig. 2c at the indicated concentrations and the concentration of IL-2 in each supernatant was measured by ELISA. The right graph shows the recovery rate of IL-2 production by each anti-PD-1 at the different concentrations. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.CC BY · PubMed Central
Fig. 5 PD-L2 outcompetes PD-L1 in binding to PD-1 at the TCR–PD-1 microclusters. a The mPD-L1–GPI (red, middle) and mPD-L2–GPI (green, bottom) were labeled with AlexaFluor 647 and AlexaFluor 488, respectively, and reconstituted into SLBs as in Fig. 1a in the different densities indicated above the images. 2D12 expressing mPD-1–HaloTag (top, cyan) were preincubated with HaloTag ligand–TMR and real-time imaged by confocal microscopy at 2 min after the T cell-bilayer contact. b Images of cells in a at mPD-L1–GPI (75 molecules/μm2) + mPD-L2–GPI (300) (left) or mPD-L1–GPI (300) + mPD-L2–GPI (75) (right). The yellow squares in the left panels are magnified in the right three panels. Yellow enclosures show PD-L1 or PD-L2 clusters colocalized with PD-1 microclusters. Green enclosures show blank where PD-1 microclusters formed. c The graphs show the percentage of T cells forming PD-1 microclusters composed of either PD-L1, PD-L2, or PD-L1 + L2 at the different densities of mPD-L1–GPI and mPD-L2–GPI in a. d Silica beads were coated with the same SLBs as in a with different densities of mPD-L1–GPI and mPD-L2–GPI and prepulsed with MCC88–103 to use as engineered antigen presenting cells. 2D12 expressing mPD-1 were stimulated by these silica beads for 16 h and the concentration of IL-2 in each supernatant was measured by ELISA. e 2D12 expressing mPD-1–EGFP (green) were prestained with DyLight 650-labeled H57 Fab (red) and real-time imaged on an SLB with both mPD-L1–GPI and mPD-L2–GPI in the absence or presence of each antibody as in Fig. 2a. The graph shows the percentage of T cells forming PD-1 microclusters (n = 30). f The cells in e were stimulated by 16h-aggregation culture with 10 μM of MCC88–103 and the concentration of IL-2 in each supernatant was measured by ELISA. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). *p < 0.05, **p < 0.01, ****p < 0.0001.
Fig. 5 PD-L2 outcompetes PD-L1 in binding to PD-1 at the TCR–PD-1 microclusters. a The mPD-L1–GPI (red, middle) and mPD-L2–GPI (green, bottom) were labeled with AlexaFluor 647 and AlexaFluor 488, respectively, and reconstituted into SLBs as in Fig. 1a in the different densities indicated above the images. 2D12 expressing mPD-1–HaloTag (top, cyan) were preincubated with HaloTag ligand–TMR and real-time imaged by confocal microscopy at 2 min after the T cell-bilayer contact. b Images of cells in a at mPD-L1–GPI (75 molecules/μm2) + mPD-L2–GPI (300) (left) or mPD-L1–GPI (300) + mPD-L2–GPI (75) (right). The yellow squares in the left panels are magnified in the right three panels. Yellow enclosures show PD-L1 or PD-L2 clusters colocalized with PD-1 microclusters. Green enclosures show blank where PD-1 microclusters formed. c The graphs show the percentage of T cells forming PD-1 microclusters composed of either PD-L1, PD-L2, or PD-L1 + L2 at the different densities of mPD-L1–GPI and mPD-L2–GPI in a. d Silica beads were coated with the same SLBs as in a with different densities of mPD-L1–GPI and mPD-L2–GPI and prepulsed with MCC88–103 to use as engineered antigen presenting cells. 2D12 expressing mPD-1 were stimulated by these silica beads for 16 h and the concentration of IL-2 in each supernatant was measured by ELISA. e 2D12 expressing mPD-1–EGFP (green) were prestained with DyLight 650-labeled H57 Fab (red) and real-time imaged on an SLB with both mPD-L1–GPI and mPD-L2–GPI in the absence or presence of each antibody as in Fig. 2a. The graph shows the percentage of T cells forming PD-1 microclusters (n = 30). f The cells in e were stimulated by 16h-aggregation culture with 10 μM of MCC88–103 and the concentration of IL-2 in each supernatant was measured by ELISA. All data are representatives of three independent experiments. Bars, 5 μm. Error bars, SD. Statistical analysis was by one-way analysis of variance (ANOVA). *p < 0.05, **p < 0.01, ****p < 0.0001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 33

Metadata

Authors
Takehara, T., Wakamatsu, E., Machiyama, H., Nishi, W., Emoto, K., Azuma, M., Soejima, K., Fukunaga, K., & Yokosuka, T.
Affiliations
  • Tokyo Medical University (JP)
  • Kumamoto University (JP)
  • Keio University (JP)
  • Tokyo Medical and Dental University (JP)
Corresponding author
Yokosuka, Tadashi
Venue
Communications Biology
Published
2021-05-14
Volume
4
Issue
1
Pages
581-581
ISSN
2399-3642 (ISSN-L)
OpenAlex
W3161043767
Cited by
31
References
36
Citations by year
2026: 9 · 2025: 3 · 2024: 8 · 2023: 7 · 2022: 3 · 2021: 1
FWCI
1.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • MEXT | Japan Society for the Promotion of Science (JP20J10564, JP25113725, JP15H01194, JP16H06501, JP17H03600, JP19K22545, JP20H03536)
  • MEXT | JST | Precursory Research for Embryonic Science and Technology (U1114011)
  • Takeda Science Foundation
  • Naito Foundation (4465-135)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
PD-L2, PD-1, SHP2, T cell signaling, immune checkpoint, PD-L1, T cell suppression, anti-PD-1 therapy, tumor immune evasion
MeSH terms
Animals, Cells, Cultured, Dendritic Cells, Lymphocyte Activation, Mice, Inbred C57BL, Signal Transduction, Mice, Knockout, CD8-Positive T-Lymphocytes, Mice, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Programmed Cell Death 1 Receptor, Programmed Cell Death 1 Ligand 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PD‐L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment. https://app.cochat.ai/papers/10.1038/s42003-021-02111-3
The paper
Takehara, T., Wakamatsu, E., Machiyama, H., Nishi, W., Emoto, K., Azuma, M., Soejima, K., Fukunaga, K., & Yokosuka, T. (2021). PD‐L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment. Communications Biology. https://doi.org/10.1038/s42003-021-02111-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.